Al Assaad M, Michaud O, Semaan A, Sigouros M, Tranquille M, Phan A et al (2024) Whole-genome sequencing analysis of male breast cancer unveils novel structural events and potential therapeutic targets. Mod Pathol 37(4):100452. https://doi.org/10.1016/j.modpat.2024.100452
Article CAS PubMed Google Scholar
Artigas-Arias M, Curi R, Marzuca-Nassr GN (2024) Myogenic microRNAs as therapeutic targets for skeletal muscle mass wasting in breast cancer models. Int J Mol Sci 25(12). https://doi.org/10.3390/ijms25126714
Britt KL, Cuzick J, Phillips K-A (2020) Key steps for effective breast cancer prevention. Nat Rev Cancer 20(8):417–436. https://doi.org/10.1038/s41568-020-0266-x
Article CAS PubMed Google Scholar
Chen X, Yang C (2024) A novel disulfidptosis-related lncRNAs prognostic signature for prognosis predicting and immune microenvironment characterization in breast cancer. Curr Med Chem. https://doi.org/10.2174/0109298673294711240405090150
Article PubMed PubMed Central Google Scholar
Dai C, Qianjiang H, Fu R, Yang H, Shi A, Luo H (2025) Epigenetic and epitranscriptomic role of lncRNA in carcinogenesis (review). Int J Oncol 66(4). https://doi.org/10.3892/ijo.2025.5735
Dvir K, Giordano S, Leone JP (2024) Immunotherapy in breast cancer. Int J Mol Sci 25(14). https://doi.org/10.3390/ijms25147517
Folkman J (1975) Tumor angiogenesis: a possible control point in tumor growth. Ann Intern Med 82(1):96–100. https://doi.org/10.7326/0003-4819-82-1-96
Funes SC, Manrique de Lara A, Altamirano-Lagos MJ, Mackern-Oberti JP, Escobar-Vera J, Kalergis A (2019) Immune checkpoints and the regulation of tolerogenicity in dendritic cells: implications for autoimmunity and immunotherapy. Autoimmun Rev 18(4):359–68. https://doi.org/10.1016/j.autrev.2019.02.006
Article CAS PubMed Google Scholar
Garon EB, Finn RS, Hosmer W, Dering J, Ginther C, Adhami S et al (2010) Identification of common predictive markers of in vitro response to the Mek inhibitor selumetinib (AZD6244; ARRY-142886) in human breast cancer and non-small cell lung cancer cell lines. Mol Cancer Ther 9(7):1985–1994. https://doi.org/10.1158/1535-7163.MCT-10-0037
Article CAS PubMed PubMed Central Google Scholar
Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D et al (2015) The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med 21(8):938–945. https://doi.org/10.1038/nm.3909
Article CAS PubMed PubMed Central Google Scholar
Gilmour A, Cutress R, Gandhi A, Harcourt D, Little K, Mansell J et al (2021) Oncoplastic breast surgery: a guide to good practice. Eur J Surg Oncol 47(9):2272–2285. https://doi.org/10.1016/j.ejso.2021.05.006
Article CAS PubMed Google Scholar
Han C, Zhang C, Wang H, Li K, Zhao L (2021) Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma. BMC Cancer 21(1):1312. https://doi.org/10.1186/s12885-021-08987-y
Article CAS PubMed PubMed Central Google Scholar
His M, Gunter MJ, Keski-Rahkonen P, Rinaldi S (2024) Application of metabolomics to epidemiologic studies of breast cancer: new perspectives for etiology and prevention. J Clin Oncol 42(1):103–115. https://doi.org/10.1200/JCO.22.02754
Horton ER, Byron A, Askari JA, Ng DHJ, Millon-Frémillon A, Robertson J et al (2015) Definition of a consensus integrin adhesome and its dynamics during adhesion complex assembly and disassembly. Nat Cell Biol 17(12):1577–1587. https://doi.org/10.1038/ncb3257
Article CAS PubMed PubMed Central Google Scholar
Howe KL, Achuthan P, Allen J, Allen J, Alvarez-Jarreta J, Amode MR et al (2021) Ensembl 2021. Nucleic Acids Res 49(D1):D884–D891. https://doi.org/10.1093/nar/gkaa942
Article CAS PubMed Google Scholar
Hu M, Li T, Ma X, Liu S, Li C, Huang Z et al (2023) Macrophage lineage cells-derived migrasomes activate complement-dependent blood-brain barrier damage in cerebral amyloid angiopathy mouse model. Nat Commun 14(1):3945. https://doi.org/10.1038/s41467-023-39693-x
Article CAS PubMed PubMed Central Google Scholar
Huang W-J, Zhang M-L, Wang W, Jia Q-C, Yuan J-R, Zhang X et al (2022) Preoperative pectoralis muscle index predicts distant metastasis-free survival in breast cancer patients. Front Oncol 12:854137. https://doi.org/10.3389/fonc.2022.854137
Article PubMed PubMed Central Google Scholar
Humphries B, Wang Z, Oom AL, Fisher T, Tan D, Cui Y et al (2014) MicroRNA-200b targets protein kinase Cα and suppresses triple-negative breast cancer metastasis. Carcinogenesis 35(10):2254–2263. https://doi.org/10.1093/carcin/bgu133
Article CAS PubMed PubMed Central Google Scholar
Imyanitov EN, Levchenko EV, Kuligina ES, Orlov SV (2020) Treating non-small cell lung cancer with selumetinib: an up-to-date drug evaluation. Expert Opin Pharmacother 21(16):1943–1953. https://doi.org/10.1080/14656566.2020.1798930
Article CAS PubMed Google Scholar
Jiang D, He J, Yu L (2025) The migrasome, an organelle for cell-cell communication. Trends Cell Biol 35(3):205–216. https://doi.org/10.1016/j.tcb.2024.05.003
Article CAS PubMed Google Scholar
Jiang T, Wang Y, Chen X, Xia W, Xue S, Gu L et al (2023b) Neutrophil extracellular traps (NETs)-related lncRNAs signature for predicting prognosis and the immune microenvironment in breast cancer. Front Cell Dev Biol 11:1117637. https://doi.org/10.3389/fcell.2023.1117637
Article PubMed PubMed Central Google Scholar
Jiang Y, Liu X, Ye J, Ma Y, Mao J, Feng D et al (2023a) Migrasomes, a new mode of intercellular communication. Cell Commun Signal 21(1):105. https://doi.org/10.1186/s12964-023-01121-4
Article CAS PubMed PubMed Central Google Scholar
Kao K-C, Vilbois S, Tsai C-H, Ho P-C (2022) Metabolic communication in the tumour-immune microenvironment. Nat Cell Biol 24(11):1574–1583. https://doi.org/10.1038/s41556-022-01002-x
Article CAS PubMed Google Scholar
Katsura C, Ogunmwonyi I, Kankam HK, Saha S (2022) Breast cancer: presentation, investigation and management. Br J Hosp Med (Lond) 83(2):1–7. https://doi.org/10.12968/hmed.2021.0459
Kuczynski EA, Vermeulen PB, Pezzella F, Kerbel RS, Reynolds AR (2019) Vessel co-option in cancer. Nat Rev Clin Oncol 16(8):469–493. https://doi.org/10.1038/s41571-019-0181-9
Article CAS PubMed Google Scholar
Le Naour F, André M, Boucheix C, Rubinstein E (2006) Membrane microdomains and proteomics: lessons from tetraspanin microdomains and comparison with lipid rafts. Proteomics 6(24):6447–6454
Li B, Chan HL, Chen P (2019) Immune checkpoint inhibitors: basics and challenges. Curr Med Chem 26(17):3009–3025. https://doi.org/10.2174/0929867324666170804143706
Article CAS PubMed Google Scholar
Li G, Li S, Jiang Y, Chen T, An Z (2025) Unleashing the power of immune checkpoints: a new strategy for enhancing Treg cells depletion to boost antitumor immunity. Int Immunopharmacol 147:113952. https://doi.org/10.1016/j.intimp.2024.113952
Article CAS PubMed Google Scholar
Liu S, Zheng Y, Li S, Du Y, Liu X, Tang H et al (2023) Integrative landscape analysis of prognostic model biomarkers and immunogenomics of disulfidptosis-related genes in breast cancer based on LASSO and WGCNA analyses. J Cancer Res Clin Oncol 149(18):16851–16867. https://doi.org/10.1007/s00432-023-05372-z
Article CAS PubMed PubMed Central Google Scholar
Liu Y, Li S, Rong W, Zeng C, Zhu X, Chen Q et al (2020) Podocyte-released migrasomes in urine serve as an indicator for early podocyte injury. Kidney Dis (Basel) 6(6):422–433. https://doi.org/10.1159/000511504
Lokhande L, Nilsson D, de Matos Rod
Comments (0)